No Data
No Data
Theriva Biologics Gets EU Orphan Drug Designation for Eye Cancer Treatment Candidate; Shares Rise
Express News | Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to Vcn-01 for the Treatment of Retinoblastoma
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
DJ NYSE American Most Active Issues
Sector Update: Health Care
Nasdaq Moves Lower; Levi Strauss Shares Slide
No Data
No Data